Hepatitis C in the News Your source for hepatitis C-related news from around the web.

Not sure what to submit? Read our news guidelines first.

Simeprevir in hepatitis C: Added benefit for certain patients

From sciencedaily.com

The drug simeprevir (trade name: Olysio) has been available since May 2014 for the treatment of adult patients with chronic hepatitis C infection. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the German Institute for Quality and Efficiency in…

Views 62 Comments 0 Likes 0
1 month
News_article

World Hepatitis Alliance launches HCV Quest

From healio.com

Hepatology | The World Hepatitis Alliance has created HCV Quest, a global survey that provides a forum for patients with hepatitis C virus, according to an announcement on the European Association for the Study of the Liver website.

Views 149 Comments 0 Likes 0
2 months

Physician advocates awareness, collaboration to combat peaking Hep C virus

From sciencedaily.com

Eliminating hepatitis C virus infection is feasible, can provide economic benefits, enhance capacity to address other health challenges, and improve health care disparities, an expert argues. More than 185 million people worldwide, 3 percent of the world's population, are living with HCV and 350,000 die each year.

Views 69 Comments 0 Likes 1
2 months
News_article

Waging War on Hepatitis C

From bloombergview.com

All over the country, state governments are grappling with the same question: "What do we do about Sovaldi?" The drug seems to be far more effective than alternatives at treating hepatitis C, a disease that, left untreated, frequently progresses to liver disease and then death. It also costs $84,000 for…

Views 205 Comments 0 Likes 0
2 months
News_article

HALLMARK, COSMOS: New HCV regimens show high cure rates

From healio.com

Infectious Disease | Novel direct-acting antiviral agents were effective in treating infection with hepatitis C virus genotype 1 - even in the hardest-to-treat patients - according to results from two major clinical trials published in the Lancet.

Views 100 Comments 0 Likes 0
2 months